Therapeutic Antibodies in Neurological Diseases: Witnessing the Continuation of the Impressive Success in Neuro-Immunotherapies

被引:1
作者
Dalakas, Marinos C. [1 ,2 ]
Wiendl, Heinz [3 ,4 ]
机构
[1] Thomas Jefferson Univ, Philadelphia, PA 19107 USA
[2] Natl & Kapodistrian Univ Athens, Neuroimmunol Unit, Athens, Greece
[3] Univ Munster, Dept Neurol, Inst Translat Neurol, Munster, Germany
[4] Univ Sydney, Brain & Mind Ctr, Sydney, NSW, Australia
关键词
D O I
10.1007/s13311-022-01266-z
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
[No abstract available]
引用
收藏
页码:687 / 690
页数:4
相关论文
共 22 条
[1]   Therapeutic Monoclonal Antibody Therapies in Chronic Autoimmune Demyelinating Neuropathies [J].
Briani, Chiara ;
Visentin, Andrea .
NEUROTHERAPEUTICS, 2022, 19 (03) :874-884
[2]   The Arrival of Anti-CGRP Monoclonal Antibodies in Migraine [J].
Cohen, Fred ;
Yuan, Hsiangkuo ;
DePoy, E. M. G. ;
Silberstein, Stephen D. .
NEUROTHERAPEUTICS, 2022, 19 (03) :922-930
[3]  
Dalakas, 2003, SEMINARS NEUROLOGY, V23
[4]  
Dalakas, 2016, J AM SOC EXPT NEUROT
[5]   Immunomodulatory effects and clinical benefits of intravenous immunoglobulin in myasthenia gravis [J].
Dalakas, Marinos C. ;
Meisel, Andreas .
EXPERT REVIEW OF NEUROTHERAPEUTICS, 2022, 22 (04) :313-318
[6]   Autoimmune Neurological Disorders with IgG4 Antibodies: a Distinct Disease Spectrum with Unique IgG4 Functions Responding to Anti-B Cell Therapies [J].
Dalakas, Marinos C. .
NEUROTHERAPEUTICS, 2022, 19 (03) :741-752
[7]   Stiff-person Syndrome and GAD Antibody-spectrum Disorders: GABAergic Neuronal Excitability, Immunopathogenesis and Update on Antibody Therapies [J].
Dalakas, Marinos C. .
NEUROTHERAPEUTICS, 2022, 19 (03) :832-847
[8]   Neuro-Immunotherapies: A 30-year Retrospective of an Overwhelming Success and a Brighter Future [J].
Dalakas, Marinos C. .
NEUROTHERAPEUTICS, 2016, 13 (01) :1-3
[9]  
Dalakas MC, 1994, SEMIN NEUROL, V14
[10]   Paraneoplastic Autoimmune Neurological Syndromes and the Role of Immune Checkpoint Inhibitors [J].
Duong, Sophie L. ;
Pruess, Harald .
NEUROTHERAPEUTICS, 2022, 19 (03) :848-863